Pestones A and B from a Fungus Pestalotiopsis sp. Bound to Mutant p53 and Changed Its Conformation

Yusaku Sadahiro1, Misaki Okubo1, Yuki Hitora1

  • 1Department of Natural Medicines, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto 862-0973, Japan.

Journal of Natural Products
|February 14, 2025
PubMed

Insights

Researchers discovered new compounds, pestones A and B, from the fungus *Pestalotiopsis* sp. These compounds reactivate mutant p53 (a cancer target) and show potent anticancer activity, offering a promising new cancer therapy strategy.

Area of Science:

  • Natural Products Chemistry
  • Cancer Biology
  • Drug Discovery

Background:

  • Oncogenic mutant p53 is a key target in cancer therapy.
  • Developing drugs to reactivate mutant p53 is a promising therapeutic strategy.
  • Fungal extracts represent a potential source for novel anticancer agents.

Purpose of the Study:

  • To isolate and characterize compounds from *Pestalotiopsis* sp. with the ability to restore mutant p53 function.
  • To evaluate the anticancer potential of isolated compounds against p53-mutated cancer cells.
  • To investigate the mechanism of action of these compounds on mutant p53.

Main Methods:

  • Bioassay-guided purification of *Pestalotiopsis* sp. extract.
  • Spectroscopic analysis (NMR, MS) for structural elucidation.
  • Cellular thermal shift assay (CETSA) and immunofluorescence staining to assess p53 interaction.
  • Cytotoxicity assays (IC50 determination) and flow cytometry for apoptosis analysis.
  • In vivo tumor growth inhibition studies in a mouse model.

Main Results:

  • Isolation of two new dimeric epoxyquinoids, pestones A (1) and B (2), and known compound rosnecatrone (3).
  • Pestones A and B were confirmed to alter mutant p53 conformation and compound 1 directly binds to mutant p53, increasing its thermostability.
  • Compounds 1 and 2 demonstrated significant cytotoxic activity against Saos-2 (p53R175H) cells (IC50 values 1.0 and 1.1 μM).
  • Compound 1 induced apoptosis in cancer cells and reduced tumor growth in vivo.

Conclusions:

  • Pestones A and B are novel dimeric epoxyquinoids with the ability to reactivate mutant p53.
  • These compounds exhibit potent anticancer activity through mechanisms involving p53 restoration, apoptosis induction, and tumor growth inhibition.
  • Pestalotiopsis sp. derived compounds represent a promising new avenue for developing targeted cancer therapies against p53-mutated cancers.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.8K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K